nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCB1—colon cancer	0.154	1	CbGaD
Verapamil—ABCC10—Vincristine—colon cancer	0.0628	0.0948	CbGbCtD
Verapamil—ABCC3—Fluorouracil—colon cancer	0.0434	0.0655	CbGbCtD
Verapamil—ABCC3—Vincristine—colon cancer	0.0395	0.0596	CbGbCtD
Verapamil—ABCC10—Methotrexate—colon cancer	0.038	0.0574	CbGbCtD
Verapamil—ABCB11—Vincristine—colon cancer	0.0341	0.0515	CbGbCtD
Verapamil—ABCC4—Fluorouracil—colon cancer	0.0331	0.05	CbGbCtD
Verapamil—ABCC1—Irinotecan—colon cancer	0.0277	0.0419	CbGbCtD
Verapamil—ABCC1—Vincristine—colon cancer	0.0243	0.0366	CbGbCtD
Verapamil—ABCC3—Methotrexate—colon cancer	0.0239	0.0361	CbGbCtD
Verapamil—SLCO1B1—Irinotecan—colon cancer	0.0234	0.0353	CbGbCtD
Verapamil—ABCC2—Irinotecan—colon cancer	0.0205	0.031	CbGbCtD
Verapamil—ABCG2—Irinotecan—colon cancer	0.0186	0.028	CbGbCtD
Verapamil—ABCC4—Methotrexate—colon cancer	0.0183	0.0276	CbGbCtD
Verapamil—ABCC2—Vincristine—colon cancer	0.018	0.0271	CbGbCtD
Verapamil—ABCG2—Fluorouracil—colon cancer	0.0178	0.0269	CbGbCtD
Verapamil—ABCG2—Vincristine—colon cancer	0.0162	0.0245	CbGbCtD
Verapamil—ABCC1—Methotrexate—colon cancer	0.0147	0.0222	CbGbCtD
Verapamil—CYP3A7—Irinotecan—colon cancer	0.0137	0.0207	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0137	0.0207	CbGbCtD
Verapamil—SLCO1A2—Methotrexate—colon cancer	0.0131	0.0198	CbGbCtD
Verapamil—CYP2B6—Irinotecan—colon cancer	0.0131	0.0197	CbGbCtD
Verapamil—SLCO1B1—Methotrexate—colon cancer	0.0124	0.0187	CbGbCtD
Verapamil—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.012	0.0181	CbGbCtD
Verapamil—CYP3A7—Vincristine—colon cancer	0.012	0.0181	CbGbCtD
Verapamil—CYP2C9—Capecitabine—colon cancer	0.0112	0.0169	CbGbCtD
Verapamil—ABCC2—Methotrexate—colon cancer	0.0109	0.0164	CbGbCtD
Verapamil—CYP3A5—Irinotecan—colon cancer	0.0103	0.0155	CbGbCtD
Verapamil—ABCG2—Methotrexate—colon cancer	0.00983	0.0148	CbGbCtD
Verapamil—CYP2C8—Fluorouracil—colon cancer	0.00949	0.0143	CbGbCtD
Verapamil—CYP3A5—Vincristine—colon cancer	0.00899	0.0136	CbGbCtD
Verapamil—CYP1A2—Fluorouracil—colon cancer	0.00735	0.0111	CbGbCtD
Verapamil—ABCB11—bile—colon cancer	0.00684	0.12	CbGeAlD
Verapamil—ABCB1—Irinotecan—colon cancer	0.0067	0.0101	CbGbCtD
Verapamil—CYP2C9—Fluorouracil—colon cancer	0.00662	0.00999	CbGbCtD
Verapamil—ABCB1—Vincristine—colon cancer	0.00585	0.00883	CbGbCtD
Verapamil—CYP3A4—Irinotecan—colon cancer	0.00401	0.00606	CbGbCtD
Verapamil—ABCB1—Methotrexate—colon cancer	0.00354	0.00535	CbGbCtD
Verapamil—CYP3A4—Vincristine—colon cancer	0.00351	0.00529	CbGbCtD
Verapamil—ABCC2—bile—colon cancer	0.00348	0.061	CbGeAlD
Verapamil—ABCC3—gall bladder—colon cancer	0.00121	0.0212	CbGeAlD
Verapamil—CACNB4—vagina—colon cancer	0.00111	0.0195	CbGeAlD
Verapamil—CACNA1G—digestive system—colon cancer	0.00105	0.0184	CbGeAlD
Verapamil—CACNB3—digestive system—colon cancer	0.000964	0.0169	CbGeAlD
Verapamil—CACNA1I—lymph node—colon cancer	0.000874	0.0153	CbGeAlD
Verapamil—CACNA1H—smooth muscle tissue—colon cancer	0.000868	0.0152	CbGeAlD
Verapamil—CACNB3—vagina—colon cancer	0.000851	0.0149	CbGeAlD
Verapamil—CYP2C18—digestive system—colon cancer	0.000768	0.0135	CbGeAlD
Verapamil—ABCB11—digestive system—colon cancer	0.000747	0.0131	CbGeAlD
Verapamil—CYP2C18—vagina—colon cancer	0.000678	0.0119	CbGeAlD
Verapamil—CACNA1B—lymph node—colon cancer	0.00067	0.0118	CbGeAlD
Verapamil—CACNA1C—smooth muscle tissue—colon cancer	0.000662	0.0116	CbGeAlD
Verapamil—CACNB2—digestive system—colon cancer	0.000648	0.0114	CbGeAlD
Verapamil—KCNJ11—lymphoid tissue—colon cancer	0.000622	0.0109	CbGeAlD
Verapamil—SLCO1B1—renal system—colon cancer	0.000611	0.0107	CbGeAlD
Verapamil—ABCC3—renal system—colon cancer	0.000579	0.0102	CbGeAlD
Verapamil—ABCC10—renal system—colon cancer	0.000577	0.0101	CbGeAlD
Verapamil—CACNB1—lymph node—colon cancer	0.000574	0.0101	CbGeAlD
Verapamil—CYP2C18—liver—colon cancer	0.000572	0.01	CbGeAlD
Verapamil—CACNB2—vagina—colon cancer	0.000572	0.01	CbGeAlD
Verapamil—ABCB11—liver—colon cancer	0.000556	0.00977	CbGeAlD
Verapamil—CACNB3—lymph node—colon cancer	0.000551	0.00966	CbGeAlD
Verapamil—CYP3A7—liver—colon cancer	0.000544	0.00955	CbGeAlD
Verapamil—SLC22A4—renal system—colon cancer	0.000542	0.00951	CbGeAlD
Verapamil—CACNA1C—digestive system—colon cancer	0.000522	0.00917	CbGeAlD
Verapamil—Contusion—Capecitabine—colon cancer	0.000517	0.00719	CcSEcCtD
Verapamil—SLC22A1—renal system—colon cancer	0.000516	0.00906	CbGeAlD
Verapamil—CACNA1H—liver—colon cancer	0.000511	0.00897	CbGeAlD
Verapamil—SCN5A—digestive system—colon cancer	0.000506	0.00889	CbGeAlD
Verapamil—SLCO1B1—digestive system—colon cancer	0.000501	0.00879	CbGeAlD
Verapamil—Cerebrovascular accident—Irinotecan—colon cancer	0.000499	0.00694	CcSEcCtD
Verapamil—SLCO1A2—renal system—colon cancer	0.000497	0.00872	CbGeAlD
Verapamil—Paralysis—Methotrexate—colon cancer	0.000483	0.00672	CcSEcCtD
Verapamil—CACNB2—liver—colon cancer	0.000482	0.00847	CbGeAlD
Verapamil—Cardiac failure—Fluorouracil—colon cancer	0.00048	0.00668	CcSEcCtD
Verapamil—ABCC10—lymphoid tissue—colon cancer	0.000479	0.0084	CbGeAlD
Verapamil—ABCC4—renal system—colon cancer	0.000478	0.0084	CbGeAlD
Verapamil—Lethargy—Fluorouracil—colon cancer	0.000478	0.00665	CcSEcCtD
Verapamil—Cardiac arrest—Vincristine—colon cancer	0.000477	0.00664	CcSEcCtD
Verapamil—ABCC3—digestive system—colon cancer	0.000475	0.00834	CbGeAlD
Verapamil—ABCC10—digestive system—colon cancer	0.000473	0.0083	CbGeAlD
Verapamil—Cardiac arrest—Irinotecan—colon cancer	0.000465	0.00647	CcSEcCtD
Verapamil—ABCC2—renal system—colon cancer	0.000463	0.00813	CbGeAlD
Verapamil—CYP3A7-CYP3A51P—liver—colon cancer	0.000463	0.00812	CbGeAlD
Verapamil—CACNA1C—vagina—colon cancer	0.000461	0.0081	CbGeAlD
Verapamil—SCN5A—vagina—colon cancer	0.000447	0.00785	CbGeAlD
Verapamil—Orthostatic hypotension—Irinotecan—colon cancer	0.000447	0.00622	CcSEcCtD
Verapamil—Cardiac arrest—Fluorouracil—colon cancer	0.000445	0.0062	CcSEcCtD
Verapamil—SLC22A4—digestive system—colon cancer	0.000445	0.0078	CbGeAlD
Verapamil—Muscular weakness—Vincristine—colon cancer	0.000443	0.00616	CcSEcCtD
Verapamil—Cramp muscle—Irinotecan—colon cancer	0.00044	0.00613	CcSEcCtD
Verapamil—ABCC10—bone marrow—colon cancer	0.000436	0.00765	CbGeAlD
Verapamil—Hepatotoxicity—Methotrexate—colon cancer	0.000435	0.00605	CcSEcCtD
Verapamil—CACNA1D—liver—colon cancer	0.000422	0.0074	CbGeAlD
Verapamil—ABCC10—vagina—colon cancer	0.000418	0.00733	CbGeAlD
Verapamil—Muscular weakness—Fluorouracil—colon cancer	0.000413	0.00575	CcSEcCtD
Verapamil—Angina pectoris—Irinotecan—colon cancer	0.000412	0.00573	CcSEcCtD
Verapamil—Sweating increased—Irinotecan—colon cancer	0.000412	0.00573	CcSEcCtD
Verapamil—SLC22A4—bone marrow—colon cancer	0.00041	0.00719	CbGeAlD
Verapamil—Petechiae—Methotrexate—colon cancer	0.000408	0.00568	CcSEcCtD
Verapamil—SLCO1A2—digestive system—colon cancer	0.000408	0.00715	CbGeAlD
Verapamil—Ecchymosis—Capecitabine—colon cancer	0.000408	0.00567	CcSEcCtD
Verapamil—Erectile dysfunction—Vincristine—colon cancer	0.0004	0.00556	CcSEcCtD
Verapamil—Angina pectoris—Fluorouracil—colon cancer	0.000394	0.00549	CcSEcCtD
Verapamil—SLC6A4—digestive system—colon cancer	0.000394	0.00691	CbGeAlD
Verapamil—Upper respiratory tract infection—Irinotecan—colon cancer	0.000393	0.00547	CcSEcCtD
Verapamil—SLC22A4—vagina—colon cancer	0.000393	0.00689	CbGeAlD
Verapamil—ABCC4—digestive system—colon cancer	0.000392	0.00689	CbGeAlD
Verapamil—CACNA1H—lymph node—colon cancer	0.000392	0.00687	CbGeAlD
Verapamil—Acute coronary syndrome—Vincristine—colon cancer	0.000381	0.00531	CcSEcCtD
Verapamil—ABCC2—digestive system—colon cancer	0.00038	0.00667	CbGeAlD
Verapamil—KCNH2—renal system—colon cancer	0.00038	0.00666	CbGeAlD
Verapamil—Myocardial infarction—Vincristine—colon cancer	0.000379	0.00528	CcSEcCtD
Verapamil—Sleep disorder—Capecitabine—colon cancer	0.000378	0.00526	CcSEcCtD
Verapamil—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000376	0.00524	CcSEcCtD
Verapamil—SLC22A1—vagina—colon cancer	0.000374	0.00656	CbGeAlD
Verapamil—SLCO1B1—liver—colon cancer	0.000373	0.00655	CbGeAlD
Verapamil—Acute coronary syndrome—Irinotecan—colon cancer	0.000371	0.00517	CcSEcCtD
Verapamil—Sweating—Vincristine—colon cancer	0.000371	0.00516	CcSEcCtD
Verapamil—CACNB2—lymph node—colon cancer	0.00037	0.00649	CbGeAlD
Verapamil—Myocardial infarction—Irinotecan—colon cancer	0.000369	0.00514	CcSEcCtD
Verapamil—ABCB1—blood vessel—colon cancer	0.000369	0.00647	CbGeAlD
Verapamil—Jaundice—Irinotecan—colon cancer	0.000367	0.00511	CcSEcCtD
Verapamil—Vascular purpura—Capecitabine—colon cancer	0.000366	0.00509	CcSEcCtD
Verapamil—ABCC4—bone marrow—colon cancer	0.000362	0.00635	CbGeAlD
Verapamil—Sweating—Irinotecan—colon cancer	0.000361	0.00503	CcSEcCtD
Verapamil—SLC22A5—renal system—colon cancer	0.000359	0.0063	CbGeAlD
Verapamil—Acute coronary syndrome—Fluorouracil—colon cancer	0.000356	0.00495	CcSEcCtD
Verapamil—Hepatic enzyme increased—Methotrexate—colon cancer	0.000355	0.00494	CcSEcCtD
Verapamil—ABCC3—liver—colon cancer	0.000354	0.00621	CbGeAlD
Verapamil—Myocardial infarction—Fluorouracil—colon cancer	0.000354	0.00492	CcSEcCtD
Verapamil—ABCC10—liver—colon cancer	0.000352	0.00618	CbGeAlD
Verapamil—KCNJ11—lymph node—colon cancer	0.000351	0.00616	CbGeAlD
Verapamil—CYP2C8—renal system—colon cancer	0.000347	0.00609	CbGeAlD
Verapamil—Hypoaesthesia—Vincristine—colon cancer	0.000346	0.00481	CcSEcCtD
Verapamil—Bradycardia—Irinotecan—colon cancer	0.000344	0.00479	CcSEcCtD
Verapamil—Vasculitis—Methotrexate—colon cancer	0.000344	0.00479	CcSEcCtD
Verapamil—Respiratory failure—Methotrexate—colon cancer	0.000342	0.00476	CcSEcCtD
Verapamil—Purpura—Capecitabine—colon cancer	0.00034	0.00473	CcSEcCtD
Verapamil—Rhinitis—Irinotecan—colon cancer	0.000339	0.00472	CcSEcCtD
Verapamil—Sinusitis—Fluorouracil—colon cancer	0.000339	0.00471	CcSEcCtD
Verapamil—Cardiac failure—Capecitabine—colon cancer	0.000335	0.00467	CcSEcCtD
Verapamil—Lethargy—Capecitabine—colon cancer	0.000334	0.00465	CcSEcCtD
Verapamil—Cerebrovascular accident—Capecitabine—colon cancer	0.000334	0.00465	CcSEcCtD
Verapamil—Diplopia—Capecitabine—colon cancer	0.000327	0.00455	CcSEcCtD
Verapamil—CYP2C19—digestive system—colon cancer	0.000326	0.00573	CbGeAlD
Verapamil—Visual impairment—Irinotecan—colon cancer	0.000326	0.00454	CcSEcCtD
Verapamil—CYP1A2—renal system—colon cancer	0.000325	0.0057	CbGeAlD
Verapamil—Rhinitis—Fluorouracil—colon cancer	0.000325	0.00452	CcSEcCtD
Verapamil—CACNA1D—lymph node—colon cancer	0.000323	0.00567	CbGeAlD
Verapamil—Hypoaesthesia—Fluorouracil—colon cancer	0.000322	0.00449	CcSEcCtD
Verapamil—Pharyngitis—Fluorouracil—colon cancer	0.000322	0.00447	CcSEcCtD
Verapamil—SLC22A1—liver—colon cancer	0.000315	0.00554	CbGeAlD
Verapamil—Flushing—Irinotecan—colon cancer	0.000314	0.00437	CcSEcCtD
Verapamil—CYP3A5—renal system—colon cancer	0.000313	0.0055	CbGeAlD
Verapamil—CYP2B6—renal system—colon cancer	0.000311	0.00547	CbGeAlD
Verapamil—Cardiac arrest—Capecitabine—colon cancer	0.000311	0.00433	CcSEcCtD
Verapamil—Alopecia—Vincristine—colon cancer	0.000307	0.00427	CcSEcCtD
Verapamil—SLCO1A2—liver—colon cancer	0.000304	0.00533	CbGeAlD
Verapamil—Ecchymosis—Methotrexate—colon cancer	0.000303	0.00422	CcSEcCtD
Verapamil—Gynaecomastia—Methotrexate—colon cancer	0.0003	0.00418	CcSEcCtD
Verapamil—Alopecia—Irinotecan—colon cancer	0.000299	0.00416	CcSEcCtD
Verapamil—Orthostatic hypotension—Capecitabine—colon cancer	0.000299	0.00416	CcSEcCtD
Verapamil—Pulmonary oedema—Methotrexate—colon cancer	0.000299	0.00416	CcSEcCtD
Verapamil—CACNA1C—lymph node—colon cancer	0.000298	0.00524	CbGeAlD
Verapamil—ABCC1—vagina—colon cancer	0.000295	0.00518	CbGeAlD
Verapamil—SLC22A5—digestive system—colon cancer	0.000294	0.00516	CbGeAlD
Verapamil—ABCC4—liver—colon cancer	0.000292	0.00513	CbGeAlD
Verapamil—Muscular weakness—Capecitabine—colon cancer	0.000289	0.00402	CcSEcCtD
Verapamil—CYP2C19—vagina—colon cancer	0.000288	0.00506	CbGeAlD
Verapamil—KCNH2—bone marrow—colon cancer	0.000287	0.00504	CbGeAlD
Verapamil—Alopecia—Fluorouracil—colon cancer	0.000286	0.00398	CcSEcCtD
Verapamil—Muscle spasms—Irinotecan—colon cancer	0.000283	0.00394	CcSEcCtD
Verapamil—ABCC2—liver—colon cancer	0.000283	0.00497	CbGeAlD
Verapamil—Influenza—Capecitabine—colon cancer	0.000283	0.00394	CcSEcCtD
Verapamil—Bronchospasm—Capecitabine—colon cancer	0.000278	0.00387	CcSEcCtD
Verapamil—Agitation—Vincristine—colon cancer	0.000278	0.00387	CcSEcCtD
Verapamil—Angina pectoris—Capecitabine—colon cancer	0.000276	0.00383	CcSEcCtD
Verapamil—Sweating increased—Capecitabine—colon cancer	0.000276	0.00383	CcSEcCtD
Verapamil—KCNH2—vagina—colon cancer	0.000275	0.00483	CbGeAlD
Verapamil—Vertigo—Vincristine—colon cancer	0.000272	0.00378	CcSEcCtD
Verapamil—ABCC3—lymph node—colon cancer	0.000271	0.00476	CbGeAlD
Verapamil—Abdominal discomfort—Capecitabine—colon cancer	0.000271	0.00377	CcSEcCtD
Verapamil—ABCC10—lymph node—colon cancer	0.00027	0.00474	CbGeAlD
Verapamil—CYP1A2—digestive system—colon cancer	0.000267	0.00468	CbGeAlD
Verapamil—Vision blurred—Fluorouracil—colon cancer	0.000266	0.0037	CcSEcCtD
Verapamil—Vertigo—Irinotecan—colon cancer	0.000265	0.00368	CcSEcCtD
Verapamil—Syncope—Irinotecan—colon cancer	0.000264	0.00367	CcSEcCtD
Verapamil—Upper respiratory tract infection—Capecitabine—colon cancer	0.000263	0.00366	CcSEcCtD
Verapamil—Convulsion—Vincristine—colon cancer	0.000262	0.00365	CcSEcCtD
Verapamil—Hypertension—Vincristine—colon cancer	0.000261	0.00363	CcSEcCtD
Verapamil—SLC22A5—vagina—colon cancer	0.00026	0.00456	CbGeAlD
Verapamil—Loss of consciousness—Irinotecan—colon cancer	0.000259	0.0036	CcSEcCtD
Verapamil—CYP2B6—lymphoid tissue—colon cancer	0.000259	0.00454	CbGeAlD
Verapamil—Myalgia—Vincristine—colon cancer	0.000257	0.00358	CcSEcCtD
Verapamil—CYP3A5—digestive system—colon cancer	0.000257	0.00451	CbGeAlD
Verapamil—CYP2B6—digestive system—colon cancer	0.000255	0.00448	CbGeAlD
Verapamil—ABCG2—bone marrow—colon cancer	0.000255	0.00448	CbGeAlD
Verapamil—Hypertension—Irinotecan—colon cancer	0.000254	0.00354	CcSEcCtD
Verapamil—SLC22A4—lymph node—colon cancer	0.000254	0.00446	CbGeAlD
Verapamil—CYP2C9—digestive system—colon cancer	0.000253	0.00444	CbGeAlD
Verapamil—CYP2C8—vagina—colon cancer	0.000252	0.00441	CbGeAlD
Verapamil—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00025	0.00348	CcSEcCtD
Verapamil—ABCC1—liver—colon cancer	0.000249	0.00437	CbGeAlD
Verapamil—Acute coronary syndrome—Capecitabine—colon cancer	0.000249	0.00346	CcSEcCtD
Verapamil—Lethargy—Methotrexate—colon cancer	0.000249	0.00346	CcSEcCtD
Verapamil—Cerebrovascular accident—Methotrexate—colon cancer	0.000249	0.00346	CcSEcCtD
Verapamil—Discomfort—Irinotecan—colon cancer	0.000248	0.00345	CcSEcCtD
Verapamil—Myocardial infarction—Capecitabine—colon cancer	0.000247	0.00344	CcSEcCtD
Verapamil—Anaphylactic shock—Vincristine—colon cancer	0.000247	0.00343	CcSEcCtD
Verapamil—Oedema—Vincristine—colon cancer	0.000247	0.00343	CcSEcCtD
Verapamil—Jaundice—Capecitabine—colon cancer	0.000246	0.00342	CcSEcCtD
Verapamil—Infection—Vincristine—colon cancer	0.000245	0.00341	CcSEcCtD
Verapamil—ABCG2—vagina—colon cancer	0.000245	0.00429	CbGeAlD
Verapamil—Convulsion—Fluorouracil—colon cancer	0.000244	0.0034	CcSEcCtD
Verapamil—CYP2C19—liver—colon cancer	0.000243	0.00427	CbGeAlD
Verapamil—Confusional state—Irinotecan—colon cancer	0.000242	0.00337	CcSEcCtD
Verapamil—Anaphylactic shock—Irinotecan—colon cancer	0.00024	0.00334	CcSEcCtD
Verapamil—Oedema—Irinotecan—colon cancer	0.00024	0.00334	CcSEcCtD
Verapamil—Chest pain—Fluorouracil—colon cancer	0.00024	0.00334	CcSEcCtD
Verapamil—Myalgia—Fluorouracil—colon cancer	0.00024	0.00334	CcSEcCtD
Verapamil—Infection—Irinotecan—colon cancer	0.000239	0.00332	CcSEcCtD
Verapamil—Hyperhidrosis—Vincristine—colon cancer	0.000239	0.00332	CcSEcCtD
Verapamil—Discomfort—Fluorouracil—colon cancer	0.000237	0.0033	CcSEcCtD
Verapamil—Shock—Irinotecan—colon cancer	0.000236	0.00329	CcSEcCtD
Verapamil—CYP3A4—renal system—colon cancer	0.000235	0.00413	CbGeAlD
Verapamil—Hyperhidrosis—Irinotecan—colon cancer	0.000232	0.00323	CcSEcCtD
Verapamil—Confusional state—Fluorouracil—colon cancer	0.000232	0.00323	CcSEcCtD
Verapamil—CYP2D6—renal system—colon cancer	0.000231	0.00406	CbGeAlD
Verapamil—Hypotension—Vincristine—colon cancer	0.000231	0.00321	CcSEcCtD
Verapamil—Bradycardia—Capecitabine—colon cancer	0.00023	0.00321	CcSEcCtD
Verapamil—Anaphylactic shock—Fluorouracil—colon cancer	0.00023	0.0032	CcSEcCtD
Verapamil—Oedema—Fluorouracil—colon cancer	0.00023	0.0032	CcSEcCtD
Verapamil—Infection—Fluorouracil—colon cancer	0.000229	0.00318	CcSEcCtD
Verapamil—CYP3A5—vagina—colon cancer	0.000227	0.00398	CbGeAlD
Verapamil—Rhinitis—Capecitabine—colon cancer	0.000227	0.00316	CcSEcCtD
Verapamil—Hepatitis—Capecitabine—colon cancer	0.000226	0.00315	CcSEcCtD
Verapamil—CYP2B6—vagina—colon cancer	0.000226	0.00396	CbGeAlD
Verapamil—Hypoaesthesia—Capecitabine—colon cancer	0.000225	0.00313	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Vincristine—colon cancer	0.000225	0.00313	CcSEcCtD
Verapamil—Pharyngitis—Capecitabine—colon cancer	0.000225	0.00313	CcSEcCtD
Verapamil—Tachycardia—Fluorouracil—colon cancer	0.000225	0.00313	CcSEcCtD
Verapamil—Hypotension—Irinotecan—colon cancer	0.000225	0.00313	CcSEcCtD
Verapamil—ABCC4—lymph node—colon cancer	0.000224	0.00393	CbGeAlD
Verapamil—Insomnia—Vincristine—colon cancer	0.000223	0.00311	CcSEcCtD
Verapamil—Oedema peripheral—Capecitabine—colon cancer	0.000223	0.0031	CcSEcCtD
Verapamil—Paraesthesia—Vincristine—colon cancer	0.000222	0.00308	CcSEcCtD
Verapamil—ABCB1—embryo—colon cancer	0.00022	0.00386	CbGeAlD
Verapamil—SLC22A5—liver—colon cancer	0.000219	0.00385	CbGeAlD
Verapamil—Visual impairment—Capecitabine—colon cancer	0.000218	0.00304	CcSEcCtD
Verapamil—Insomnia—Irinotecan—colon cancer	0.000217	0.00302	CcSEcCtD
Verapamil—ABCC2—lymph node—colon cancer	0.000217	0.00381	CbGeAlD
Verapamil—Paraesthesia—Irinotecan—colon cancer	0.000216	0.003	CcSEcCtD
Verapamil—Hypotension—Fluorouracil—colon cancer	0.000215	0.00299	CcSEcCtD
Verapamil—Dyspnoea—Irinotecan—colon cancer	0.000214	0.00298	CcSEcCtD
Verapamil—Erythema multiforme—Capecitabine—colon cancer	0.000214	0.00298	CcSEcCtD
Verapamil—Somnolence—Irinotecan—colon cancer	0.000214	0.00297	CcSEcCtD
Verapamil—Fatigue—Vincristine—colon cancer	0.000213	0.00296	CcSEcCtD
Verapamil—CYP2C8—liver—colon cancer	0.000212	0.00372	CbGeAlD
Verapamil—Dyspepsia—Irinotecan—colon cancer	0.000212	0.00294	CcSEcCtD
Verapamil—Tinnitus—Capecitabine—colon cancer	0.000211	0.00294	CcSEcCtD
Verapamil—Pain—Vincristine—colon cancer	0.000211	0.00294	CcSEcCtD
Verapamil—Constipation—Vincristine—colon cancer	0.000211	0.00294	CcSEcCtD
Verapamil—Flushing—Capecitabine—colon cancer	0.00021	0.00292	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00021	0.00292	CcSEcCtD
Verapamil—Insomnia—Fluorouracil—colon cancer	0.000208	0.0029	CcSEcCtD
Verapamil—Fatigue—Irinotecan—colon cancer	0.000207	0.00288	CcSEcCtD
Verapamil—Paraesthesia—Fluorouracil—colon cancer	0.000207	0.00288	CcSEcCtD
Verapamil—ABCG2—liver—colon cancer	0.000206	0.00362	CbGeAlD
Verapamil—Constipation—Irinotecan—colon cancer	0.000206	0.00286	CcSEcCtD
Verapamil—Pain—Irinotecan—colon cancer	0.000206	0.00286	CcSEcCtD
Verapamil—Dyspnoea—Fluorouracil—colon cancer	0.000205	0.00286	CcSEcCtD
Verapamil—Somnolence—Fluorouracil—colon cancer	0.000205	0.00285	CcSEcCtD
Verapamil—Dyspepsia—Fluorouracil—colon cancer	0.000203	0.00282	CcSEcCtD
Verapamil—Abdominal discomfort—Methotrexate—colon cancer	0.000202	0.00281	CcSEcCtD
Verapamil—Alopecia—Capecitabine—colon cancer	0.0002	0.00278	CcSEcCtD
Verapamil—CYP1A2—liver—colon cancer	0.000199	0.00349	CbGeAlD
Verapamil—Feeling abnormal—Irinotecan—colon cancer	0.000198	0.00276	CcSEcCtD
Verapamil—Pain—Fluorouracil—colon cancer	0.000197	0.00274	CcSEcCtD
Verapamil—Upper respiratory tract infection—Methotrexate—colon cancer	0.000196	0.00272	CcSEcCtD
Verapamil—Erectile dysfunction—Methotrexate—colon cancer	0.000194	0.0027	CcSEcCtD
Verapamil—CYP3A4—digestive system—colon cancer	0.000193	0.00339	CbGeAlD
Verapamil—CYP3A5—liver—colon cancer	0.000192	0.00336	CbGeAlD
Verapamil—ABCC1—lymph node—colon cancer	0.000191	0.00335	CbGeAlD
Verapamil—CYP2B6—liver—colon cancer	0.00019	0.00334	CbGeAlD
Verapamil—CYP2D6—digestive system—colon cancer	0.00019	0.00333	CbGeAlD
Verapamil—Feeling abnormal—Fluorouracil—colon cancer	0.00019	0.00264	CcSEcCtD
Verapamil—Muscle spasms—Capecitabine—colon cancer	0.000189	0.00264	CcSEcCtD
Verapamil—CYP2C9—liver—colon cancer	0.000188	0.00331	CbGeAlD
Verapamil—Drowsiness—Methotrexate—colon cancer	0.000188	0.00261	CcSEcCtD
Verapamil—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000186	0.00259	CcSEcCtD
Verapamil—Vision blurred—Capecitabine—colon cancer	0.000186	0.00258	CcSEcCtD
Verapamil—Tremor—Capecitabine—colon cancer	0.000185	0.00257	CcSEcCtD
Verapamil—Urticaria—Fluorouracil—colon cancer	0.000183	0.00254	CcSEcCtD
Verapamil—Hypersensitivity—Vincristine—colon cancer	0.000182	0.00253	CcSEcCtD
Verapamil—Sweating—Methotrexate—colon cancer	0.00018	0.0025	CcSEcCtD
Verapamil—ABCB1—epithelium—colon cancer	0.00018	0.00315	CbGeAlD
Verapamil—KCNH2—lymph node—colon cancer	0.000178	0.00312	CbGeAlD
Verapamil—Vertigo—Capecitabine—colon cancer	0.000177	0.00246	CcSEcCtD
Verapamil—Hypersensitivity—Irinotecan—colon cancer	0.000177	0.00246	CcSEcCtD
Verapamil—Asthenia—Vincristine—colon cancer	0.000177	0.00246	CcSEcCtD
Verapamil—Syncope—Capecitabine—colon cancer	0.000177	0.00246	CcSEcCtD
Verapamil—Palpitations—Capecitabine—colon cancer	0.000174	0.00242	CcSEcCtD
Verapamil—Loss of consciousness—Capecitabine—colon cancer	0.000173	0.00241	CcSEcCtD
Verapamil—Asthenia—Irinotecan—colon cancer	0.000172	0.0024	CcSEcCtD
Verapamil—Hypertension—Capecitabine—colon cancer	0.00017	0.00237	CcSEcCtD
Verapamil—Hypersensitivity—Fluorouracil—colon cancer	0.00017	0.00236	CcSEcCtD
Verapamil—Diarrhoea—Vincristine—colon cancer	0.000169	0.00235	CcSEcCtD
Verapamil—Hepatitis—Methotrexate—colon cancer	0.000169	0.00235	CcSEcCtD
Verapamil—SLC22A5—lymph node—colon cancer	0.000168	0.00295	CbGeAlD
Verapamil—Myalgia—Capecitabine—colon cancer	0.000168	0.00234	CcSEcCtD
Verapamil—Arthralgia—Capecitabine—colon cancer	0.000168	0.00234	CcSEcCtD
Verapamil—Chest pain—Capecitabine—colon cancer	0.000168	0.00234	CcSEcCtD
Verapamil—Pharyngitis—Methotrexate—colon cancer	0.000167	0.00233	CcSEcCtD
Verapamil—ABCB1—renal system—colon cancer	0.000166	0.00292	CbGeAlD
Verapamil—Discomfort—Capecitabine—colon cancer	0.000166	0.00231	CcSEcCtD
Verapamil—Diarrhoea—Irinotecan—colon cancer	0.000164	0.00229	CcSEcCtD
Verapamil—Dry mouth—Capecitabine—colon cancer	0.000164	0.00228	CcSEcCtD
Verapamil—Dizziness—Vincristine—colon cancer	0.000163	0.00227	CcSEcCtD
Verapamil—Pruritus—Fluorouracil—colon cancer	0.000163	0.00227	CcSEcCtD
Verapamil—Visual impairment—Methotrexate—colon cancer	0.000162	0.00226	CcSEcCtD
Verapamil—Confusional state—Capecitabine—colon cancer	0.000162	0.00226	CcSEcCtD
Verapamil—Oedema—Capecitabine—colon cancer	0.000161	0.00224	CcSEcCtD
Verapamil—Infection—Capecitabine—colon cancer	0.00016	0.00222	CcSEcCtD
Verapamil—Erythema multiforme—Methotrexate—colon cancer	0.000159	0.00222	CcSEcCtD
Verapamil—Dizziness—Irinotecan—colon cancer	0.000159	0.00221	CcSEcCtD
Verapamil—Shock—Capecitabine—colon cancer	0.000158	0.0022	CcSEcCtD
Verapamil—ABCG2—lymph node—colon cancer	0.000158	0.00278	CbGeAlD
Verapamil—Diarrhoea—Fluorouracil—colon cancer	0.000157	0.00219	CcSEcCtD
Verapamil—Tinnitus—Methotrexate—colon cancer	0.000157	0.00219	CcSEcCtD
Verapamil—Tachycardia—Capecitabine—colon cancer	0.000157	0.00218	CcSEcCtD
Verapamil—Vomiting—Vincristine—colon cancer	0.000157	0.00218	CcSEcCtD
Verapamil—Rash—Vincristine—colon cancer	0.000156	0.00217	CcSEcCtD
Verapamil—Hyperhidrosis—Capecitabine—colon cancer	0.000156	0.00216	CcSEcCtD
Verapamil—Dermatitis—Vincristine—colon cancer	0.000155	0.00216	CcSEcCtD
Verapamil—Headache—Vincristine—colon cancer	0.000155	0.00215	CcSEcCtD
Verapamil—Vomiting—Irinotecan—colon cancer	0.000153	0.00213	CcSEcCtD
Verapamil—Dizziness—Fluorouracil—colon cancer	0.000152	0.00212	CcSEcCtD
Verapamil—Rash—Irinotecan—colon cancer	0.000152	0.00211	CcSEcCtD
Verapamil—Dermatitis—Irinotecan—colon cancer	0.000151	0.00211	CcSEcCtD
Verapamil—Headache—Irinotecan—colon cancer	0.000151	0.0021	CcSEcCtD
Verapamil—Hypotension—Capecitabine—colon cancer	0.00015	0.00209	CcSEcCtD
Verapamil—Alopecia—Methotrexate—colon cancer	0.000149	0.00207	CcSEcCtD
Verapamil—Nausea—Vincristine—colon cancer	0.000147	0.00204	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000147	0.00204	CcSEcCtD
Verapamil—Vomiting—Fluorouracil—colon cancer	0.000146	0.00204	CcSEcCtD
Verapamil—Insomnia—Capecitabine—colon cancer	0.000145	0.00202	CcSEcCtD
Verapamil—Rash—Fluorouracil—colon cancer	0.000145	0.00202	CcSEcCtD
Verapamil—Dermatitis—Fluorouracil—colon cancer	0.000145	0.00202	CcSEcCtD
Verapamil—Paraesthesia—Capecitabine—colon cancer	0.000144	0.00201	CcSEcCtD
Verapamil—Headache—Fluorouracil—colon cancer	0.000144	0.00201	CcSEcCtD
Verapamil—CYP3A4—liver—colon cancer	0.000144	0.00252	CbGeAlD
Verapamil—Dyspnoea—Capecitabine—colon cancer	0.000143	0.002	CcSEcCtD
Verapamil—Nausea—Irinotecan—colon cancer	0.000143	0.00199	CcSEcCtD
Verapamil—Dyspepsia—Capecitabine—colon cancer	0.000142	0.00197	CcSEcCtD
Verapamil—CYP2D6—liver—colon cancer	0.000141	0.00248	CbGeAlD
Verapamil—Fatigue—Capecitabine—colon cancer	0.000139	0.00193	CcSEcCtD
Verapamil—Vision blurred—Methotrexate—colon cancer	0.000138	0.00192	CcSEcCtD
Verapamil—ABCB1—lymphoid tissue—colon cancer	0.000138	0.00243	CbGeAlD
Verapamil—Constipation—Capecitabine—colon cancer	0.000138	0.00191	CcSEcCtD
Verapamil—Pain—Capecitabine—colon cancer	0.000138	0.00191	CcSEcCtD
Verapamil—Nausea—Fluorouracil—colon cancer	0.000137	0.0019	CcSEcCtD
Verapamil—ABCB1—digestive system—colon cancer	0.000137	0.0024	CbGeAlD
Verapamil—Feeling abnormal—Capecitabine—colon cancer	0.000133	0.00184	CcSEcCtD
Verapamil—Vertigo—Methotrexate—colon cancer	0.000132	0.00183	CcSEcCtD
Verapamil—Urticaria—Capecitabine—colon cancer	0.000128	0.00178	CcSEcCtD
Verapamil—Convulsion—Methotrexate—colon cancer	0.000127	0.00177	CcSEcCtD
Verapamil—ABCB1—bone marrow—colon cancer	0.000126	0.00221	CbGeAlD
Verapamil—Myalgia—Methotrexate—colon cancer	0.000125	0.00174	CcSEcCtD
Verapamil—Arthralgia—Methotrexate—colon cancer	0.000125	0.00174	CcSEcCtD
Verapamil—Chest pain—Methotrexate—colon cancer	0.000125	0.00174	CcSEcCtD
Verapamil—Discomfort—Methotrexate—colon cancer	0.000123	0.00172	CcSEcCtD
Verapamil—Confusional state—Methotrexate—colon cancer	0.000121	0.00168	CcSEcCtD
Verapamil—ABCB1—vagina—colon cancer	0.000121	0.00212	CbGeAlD
Verapamil—Anaphylactic shock—Methotrexate—colon cancer	0.00012	0.00167	CcSEcCtD
Verapamil—Infection—Methotrexate—colon cancer	0.000119	0.00166	CcSEcCtD
Verapamil—Hypersensitivity—Capecitabine—colon cancer	0.000119	0.00165	CcSEcCtD
Verapamil—Hyperhidrosis—Methotrexate—colon cancer	0.000116	0.00161	CcSEcCtD
Verapamil—Asthenia—Capecitabine—colon cancer	0.000115	0.00161	CcSEcCtD
Verapamil—Pruritus—Capecitabine—colon cancer	0.000114	0.00158	CcSEcCtD
Verapamil—Hypotension—Methotrexate—colon cancer	0.000112	0.00156	CcSEcCtD
Verapamil—Diarrhoea—Capecitabine—colon cancer	0.00011	0.00153	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000109	0.00152	CcSEcCtD
Verapamil—Insomnia—Methotrexate—colon cancer	0.000108	0.00151	CcSEcCtD
Verapamil—Paraesthesia—Methotrexate—colon cancer	0.000108	0.0015	CcSEcCtD
Verapamil—Dyspnoea—Methotrexate—colon cancer	0.000107	0.00149	CcSEcCtD
Verapamil—Somnolence—Methotrexate—colon cancer	0.000106	0.00148	CcSEcCtD
Verapamil—Dizziness—Capecitabine—colon cancer	0.000106	0.00148	CcSEcCtD
Verapamil—Dyspepsia—Methotrexate—colon cancer	0.000105	0.00147	CcSEcCtD
Verapamil—Fatigue—Methotrexate—colon cancer	0.000103	0.00144	CcSEcCtD
Verapamil—Pain—Methotrexate—colon cancer	0.000102	0.00142	CcSEcCtD
Verapamil—Vomiting—Capecitabine—colon cancer	0.000102	0.00142	CcSEcCtD
Verapamil—ABCB1—liver—colon cancer	0.000102	0.00179	CbGeAlD
Verapamil—Rash—Capecitabine—colon cancer	0.000101	0.00141	CcSEcCtD
Verapamil—Dermatitis—Capecitabine—colon cancer	0.000101	0.00141	CcSEcCtD
Verapamil—Headache—Capecitabine—colon cancer	0.000101	0.0014	CcSEcCtD
Verapamil—Feeling abnormal—Methotrexate—colon cancer	9.87e-05	0.00137	CcSEcCtD
Verapamil—Nausea—Capecitabine—colon cancer	9.55e-05	0.00133	CcSEcCtD
Verapamil—Urticaria—Methotrexate—colon cancer	9.51e-05	0.00132	CcSEcCtD
Verapamil—Hypersensitivity—Methotrexate—colon cancer	8.82e-05	0.00123	CcSEcCtD
Verapamil—Asthenia—Methotrexate—colon cancer	8.59e-05	0.0012	CcSEcCtD
Verapamil—Pruritus—Methotrexate—colon cancer	8.47e-05	0.00118	CcSEcCtD
Verapamil—Diarrhoea—Methotrexate—colon cancer	8.19e-05	0.00114	CcSEcCtD
Verapamil—Dizziness—Methotrexate—colon cancer	7.92e-05	0.0011	CcSEcCtD
Verapamil—ABCB1—lymph node—colon cancer	7.8e-05	0.00137	CbGeAlD
Verapamil—Vomiting—Methotrexate—colon cancer	7.61e-05	0.00106	CcSEcCtD
Verapamil—Rash—Methotrexate—colon cancer	7.55e-05	0.00105	CcSEcCtD
Verapamil—Dermatitis—Methotrexate—colon cancer	7.54e-05	0.00105	CcSEcCtD
Verapamil—Headache—Methotrexate—colon cancer	7.5e-05	0.00104	CcSEcCtD
Verapamil—Nausea—Methotrexate—colon cancer	7.11e-05	0.00099	CcSEcCtD
Verapamil—CACNA1C—Developmental Biology—VEGFA—colon cancer	1.69e-05	0.000307	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—NRAS—colon cancer	1.68e-05	0.000307	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PTGS2—colon cancer	1.67e-05	0.000305	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—NRAS—colon cancer	1.66e-05	0.000303	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—KRAS—colon cancer	1.63e-05	0.000297	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.62e-05	0.000295	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CHST5—colon cancer	1.57e-05	0.000286	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ODC1—colon cancer	1.57e-05	0.000286	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—TGFB1—colon cancer	1.56e-05	0.000285	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ABCB1—colon cancer	1.55e-05	0.000283	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—TGFB1—colon cancer	1.55e-05	0.000282	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—EGFR—colon cancer	1.53e-05	0.000279	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.53e-05	0.000279	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—TYMS—colon cancer	1.53e-05	0.000278	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—EGFR—colon cancer	1.52e-05	0.000276	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—AKT1—colon cancer	1.51e-05	0.000275	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.49e-05	0.000272	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.49e-05	0.000271	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—EP300—colon cancer	1.48e-05	0.00027	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—EP300—colon cancer	1.47e-05	0.000268	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—HRAS—colon cancer	1.46e-05	0.000267	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ABCB1—colon cancer	1.45e-05	0.000265	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—KRAS—colon cancer	1.45e-05	0.000264	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—KRAS—colon cancer	1.43e-05	0.000261	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ABCB1—colon cancer	1.43e-05	0.000261	CbGpPWpGaD
Verapamil—SLC22A1—Transmission across Chemical Synapses—HRAS—colon cancer	1.43e-05	0.000261	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—SRC—colon cancer	1.43e-05	0.000261	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—TYMS—colon cancer	1.43e-05	0.00026	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.42e-05	0.00026	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.42e-05	0.000259	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—TYMS—colon cancer	1.41e-05	0.000256	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ABCB1—colon cancer	1.39e-05	0.000254	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—VEGFA—colon cancer	1.39e-05	0.000254	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—EP300—colon cancer	1.39e-05	0.000254	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—HRAS—colon cancer	1.39e-05	0.000253	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.38e-05	0.000252	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—NRAS—colon cancer	1.38e-05	0.000251	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—TYMS—colon cancer	1.37e-05	0.000249	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.37e-05	0.000249	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.34e-05	0.000245	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.34e-05	0.000244	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PPARG—colon cancer	1.3e-05	0.000237	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—AKT1—colon cancer	1.29e-05	0.000236	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TGFB1—colon cancer	1.28e-05	0.000233	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.27e-05	0.000232	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.27e-05	0.000232	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PPARG—colon cancer	1.24e-05	0.000226	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.24e-05	0.000226	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.24e-05	0.000225	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PPARG—colon cancer	1.23e-05	0.000224	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—HRAS—colon cancer	1.23e-05	0.000224	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—AKT1—colon cancer	1.22e-05	0.000223	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—HRAS—colon cancer	1.22e-05	0.000222	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ABCB1—colon cancer	1.21e-05	0.000221	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ODC1—colon cancer	1.21e-05	0.000221	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CHST5—colon cancer	1.21e-05	0.000221	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.2e-05	0.000219	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—TYMS—colon cancer	1.19e-05	0.000217	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—KRAS—colon cancer	1.18e-05	0.000216	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.12e-05	0.000203	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.11e-05	0.000202	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.1e-05	0.000201	CbGpPWpGaD
Verapamil—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.1e-05	0.0002	CbGpPWpGaD
Verapamil—SLC22A1—Neuronal System—HRAS—colon cancer	1.1e-05	0.0002	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—PIK3CA—colon cancer	1.1e-05	0.0002	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ABCB1—colon cancer	1.09e-05	0.000199	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—PIK3CA—colon cancer	1.09e-05	0.000198	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—AKT1—colon cancer	1.09e-05	0.000198	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.08e-05	0.000198	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PPARG—colon cancer	1.08e-05	0.000197	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—AKT1—colon cancer	1.08e-05	0.000196	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—TYMS—colon cancer	1.07e-05	0.000195	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.06e-05	0.000193	CbGpPWpGaD
Verapamil—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.05e-05	0.000192	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—colon cancer	1.05e-05	0.000192	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ABCB1—colon cancer	1.04e-05	0.000189	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—PIK3CA—colon cancer	1.03e-05	0.000188	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.02e-05	0.000187	CbGpPWpGaD
Verapamil—ABCC1—Disease—FGFR3—colon cancer	1.02e-05	0.000187	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PTGS2—colon cancer	1.02e-05	0.000186	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—TYMS—colon cancer	1.02e-05	0.000186	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PPARG—colon cancer	1.01e-05	0.000184	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—HRAS—colon cancer	1.01e-05	0.000183	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PPARG—colon cancer	9.96e-06	0.000182	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PTGS2—colon cancer	9.76e-06	0.000178	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PPARG—colon cancer	9.69e-06	0.000177	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PTGS2—colon cancer	9.68e-06	0.000177	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ABCB1—colon cancer	9.6e-06	0.000175	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ABCB1—colon cancer	9.52e-06	0.000174	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—TYMS—colon cancer	9.43e-06	0.000172	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.4e-06	0.000171	CbGpPWpGaD
Verapamil—ABCC1—Disease—APC—colon cancer	9.4e-06	0.000171	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—TYMS—colon cancer	9.35e-06	0.00017	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.31e-06	0.00017	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.17e-06	0.000167	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	9.1e-06	0.000166	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—AKT1—colon cancer	8.95e-06	0.000163	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—AKT1—colon cancer	8.89e-06	0.000162	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ABCB1—colon cancer	8.86e-06	0.000162	CbGpPWpGaD
Verapamil—ABCC1—Disease—BRAF—colon cancer	8.83e-06	0.000161	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—TYMS—colon cancer	8.7e-06	0.000159	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PTGS2—colon cancer	8.51e-06	0.000155	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—EP300—colon cancer	8.5e-06	0.000155	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PPARG—colon cancer	8.44e-06	0.000154	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—AKT1—colon cancer	8.41e-06	0.000153	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.31e-06	0.000152	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.25e-06	0.00015	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—EP300—colon cancer	8.11e-06	0.000148	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—EP300—colon cancer	8.05e-06	0.000147	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PTGS2—colon cancer	7.95e-06	0.000145	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.84e-06	0.000143	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PTGS2—colon cancer	7.84e-06	0.000143	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	7.68e-06	0.00014	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PTGS2—colon cancer	7.62e-06	0.000139	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PPARG—colon cancer	7.59e-06	0.000138	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.58e-06	0.000138	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.33e-06	0.000134	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PPARG—colon cancer	7.22e-06	0.000132	CbGpPWpGaD
Verapamil—ABCC1—Disease—PTGS2—colon cancer	7.13e-06	0.00013	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—EP300—colon cancer	7.08e-06	0.000129	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ABCB1—colon cancer	7.04e-06	0.000128	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—TYMS—colon cancer	6.91e-06	0.000126	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ABCB1—colon cancer	6.88e-06	0.000125	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—TYMS—colon cancer	6.76e-06	0.000123	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PPARG—colon cancer	6.68e-06	0.000122	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PTGS2—colon cancer	6.64e-06	0.000121	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PPARG—colon cancer	6.62e-06	0.000121	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—EP300—colon cancer	6.61e-06	0.000121	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.54e-06	0.000119	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—EP300—colon cancer	6.52e-06	0.000119	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.48e-06	0.000118	CbGpPWpGaD
Verapamil—ABCC1—Disease—CTNNB1—colon cancer	6.38e-06	0.000116	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—EP300—colon cancer	6.34e-06	0.000116	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—PIK3CA—colon cancer	6.29e-06	0.000115	CbGpPWpGaD
Verapamil—ABCC1—Disease—CDKN1A—colon cancer	6.24e-06	0.000114	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PPARG—colon cancer	6.16e-06	0.000112	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.09e-06	0.000111	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—PIK3CA—colon cancer	6e-06	0.000109	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PTGS2—colon cancer	5.97e-06	0.000109	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.96e-06	0.000109	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ABCB1—colon cancer	5.96e-06	0.000109	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—PIK3CA—colon cancer	5.96e-06	0.000109	CbGpPWpGaD
Verapamil—ABCC1—Disease—EP300—colon cancer	5.93e-06	0.000108	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—TYMS—colon cancer	5.85e-06	0.000107	CbGpPWpGaD
Verapamil—ABCC1—Disease—SRC—colon cancer	5.77e-06	0.000105	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PTGS2—colon cancer	5.68e-06	0.000104	CbGpPWpGaD
Verapamil—ABCC1—Disease—NRAS—colon cancer	5.55e-06	0.000101	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—EP300—colon cancer	5.52e-06	0.000101	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.44e-06	9.91e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ABCB1—colon cancer	5.32e-06	9.7e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PTGS2—colon cancer	5.26e-06	9.58e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—PIK3CA—colon cancer	5.23e-06	9.54e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—TYMS—colon cancer	5.23e-06	9.53e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PTGS2—colon cancer	5.21e-06	9.5e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—MYC—colon cancer	5.17e-06	9.43e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—TGFB1—colon cancer	5.16e-06	9.4e-05	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—AKT1—colon cancer	5.14e-06	9.37e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—TYMS—colon cancer	5.1e-06	9.3e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.09e-06	9.29e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—colon cancer	5.06e-06	9.22e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—EP300—colon cancer	4.97e-06	9.06e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.96e-06	9.04e-05	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—AKT1—colon cancer	4.9e-06	8.94e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PPARG—colon cancer	4.9e-06	8.93e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ABCB1—colon cancer	4.89e-06	8.92e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—PIK3CA—colon cancer	4.89e-06	8.92e-05	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—AKT1—colon cancer	4.87e-06	8.87e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ABCB1—colon cancer	4.85e-06	8.84e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PTGS2—colon cancer	4.85e-06	8.84e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—PIK3CA—colon cancer	4.82e-06	8.79e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—TYMS—colon cancer	4.81e-06	8.76e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PPARG—colon cancer	4.79e-06	8.73e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—KRAS—colon cancer	4.78e-06	8.71e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—TYMS—colon cancer	4.76e-06	8.69e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—EP300—colon cancer	4.72e-06	8.61e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—PIK3CA—colon cancer	4.69e-06	8.55e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.51e-06	8.22e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—PIK3CA—colon cancer	4.39e-06	8e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—EP300—colon cancer	4.37e-06	7.97e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—EP300—colon cancer	4.33e-06	7.9e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—AKT1—colon cancer	4.28e-06	7.8e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.24e-06	7.72e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PPARG—colon cancer	4.15e-06	7.56e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ABCB1—colon cancer	4.15e-06	7.56e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—PIK3CA—colon cancer	4.08e-06	7.45e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—TYMS—colon cancer	4.07e-06	7.42e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—HRAS—colon cancer	4.06e-06	7.4e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—EP300—colon cancer	4.03e-06	7.35e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.02e-06	7.33e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—AKT1—colon cancer	4e-06	7.29e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—AKT1—colon cancer	3.94e-06	7.18e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PTGS2—colon cancer	3.85e-06	7.02e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—AKT1—colon cancer	3.83e-06	6.99e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PTGS2—colon cancer	3.77e-06	6.87e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PPARG—colon cancer	3.7e-06	6.75e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—PIK3CA—colon cancer	3.68e-06	6.7e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.67e-06	6.69e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PPARG—colon cancer	3.61e-06	6.59e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—AKT1—colon cancer	3.59e-06	6.54e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—PIK3CA—colon cancer	3.49e-06	6.37e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PPARG—colon cancer	3.4e-06	6.21e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PPARG—colon cancer	3.38e-06	6.15e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—AKT1—colon cancer	3.34e-06	6.08e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PTGS2—colon cancer	3.26e-06	5.95e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—PIK3CA—colon cancer	3.23e-06	5.9e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—PIK3CA—colon cancer	3.21e-06	5.84e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—EP300—colon cancer	3.2e-06	5.84e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ABCB1—colon cancer	3.2e-06	5.83e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—TYMS—colon cancer	3.14e-06	5.73e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.13e-06	5.71e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—EP300—colon cancer	3.13e-06	5.71e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—AKT1—colon cancer	3e-06	5.47e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—PIK3CA—colon cancer	2.98e-06	5.44e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PTGS2—colon cancer	2.91e-06	5.31e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PPARG—colon cancer	2.88e-06	5.26e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—AKT1—colon cancer	2.85e-06	5.2e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PTGS2—colon cancer	2.84e-06	5.18e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—EP300—colon cancer	2.71e-06	4.95e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PTGS2—colon cancer	2.68e-06	4.88e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PTGS2—colon cancer	2.66e-06	4.84e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—AKT1—colon cancer	2.64e-06	4.82e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—AKT1—colon cancer	2.62e-06	4.77e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—AKT1—colon cancer	2.44e-06	4.44e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—EP300—colon cancer	2.42e-06	4.42e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—PIK3CA—colon cancer	2.37e-06	4.32e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—EP300—colon cancer	2.36e-06	4.31e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—PIK3CA—colon cancer	2.32e-06	4.22e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PTGS2—colon cancer	2.27e-06	4.14e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—EP300—colon cancer	2.23e-06	4.06e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PPARG—colon cancer	2.23e-06	4.06e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—EP300—colon cancer	2.21e-06	4.03e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—PIK3CA—colon cancer	2.01e-06	3.66e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—AKT1—colon cancer	1.94e-06	3.53e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—AKT1—colon cancer	1.89e-06	3.45e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—EP300—colon cancer	1.89e-06	3.44e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—PIK3CA—colon cancer	1.79e-06	3.27e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PTGS2—colon cancer	1.75e-06	3.19e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—PIK3CA—colon cancer	1.75e-06	3.19e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—PIK3CA—colon cancer	1.65e-06	3e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—AKT1—colon cancer	1.64e-06	2.99e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—PIK3CA—colon cancer	1.63e-06	2.98e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—AKT1—colon cancer	1.46e-06	2.67e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—EP300—colon cancer	1.46e-06	2.65e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—AKT1—colon cancer	1.43e-06	2.6e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—PIK3CA—colon cancer	1.4e-06	2.54e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—AKT1—colon cancer	1.35e-06	2.45e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—AKT1—colon cancer	1.33e-06	2.43e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—AKT1—colon cancer	1.14e-06	2.08e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—PIK3CA—colon cancer	1.08e-06	1.96e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—AKT1—colon cancer	8.8e-07	1.6e-05	CbGpPWpGaD
